Article Information
History
- July 14, 2023.
Article Versions
- Version 1 (December 5, 2022 - 17:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Agnieszka Lemanska1,*,
- Colm Andrews2,
- Louis Fisher2,
- Seb Bacon2,
- Adam Frampton3,4,
- Amir Mehrkar2,
- Peter Inglesby2,
- Simon Davy2,
- Keith J Roberts5,
- Praveetha Patalay6,
- Ben Goldacre2,
- Brian MacKenna2,
- The OpenSAFELY Collaborative¥ and
- Alex Walker2
- 1Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK
- 2Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- 3Oncology Section, Surrey Cancer Research Institute, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK
- 4HPB Surgical Unit, Royal Surrey NHS Foundation Trust, Guildford, UK
- 5Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
- 6Faculty of Population Health Sciences, University College London, London, UK
- ↵*a.lemanska{at}surrey.ac.uk
Posted July 14, 2023.
Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway: a cohort study using OpenSAFELY-TPP
